Clinical Trial Update: An Open Study for Steroid Resistant, Non-Thymectomized MG Patients [Phase 3]

View source ↗

Summary

Phase 3 open-label study of steroid-resistant, non-thymectomized Myasthenia Gravis patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Myasthenia Gravis | Phase 3 | Status: COMPLETED